Showing results (1461-1470 of 1,882) with videos related to
Sort By:
Pageof 189
Journal of Clinical Epidemiology|September 15, 2012
Good test-retest reproducibility for an instrument to capture self-reported melanoma risk factorsConrad J Morze, Catherine M Olsen, Susan L Perry, et al.Health Psychology Review|March 9, 2025
Defining open goals for the promotion of health behaviours: a critical conceptual reviewChristian Swann, Scott G Goddard, Matthew J Schweickle, et al.Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|November 19, 2004
Ventricular mapping during atrial and right ventricular pacing: relation of electrogram parameters to ventricular tachycardia reentry circuits after myocardial infarctionCorinna B Brunckhorst, Etienne Delacretaz, Kyoko Soejima, et al.The American Journal of Clinical Nutrition|April 9, 2005
Racial differences in calcium retention in response to dietary salt in adolescent girlsKarin Wigertz, Cristina Palacios, Lisa A Jackman, et al.Journal of the American Society for Mass Spectrometry|March 29, 2005
Bacterial analysis by MALDI-TOF mass spectrometry: an inter-laboratory comparisonSharon C Wunschel, Kristin H Jarman, Catherine E Petersen, et al.Journal of Medicinal Chemistry|June 1, 1986
Quinazoline antifolates inhibiting thymidylate synthase: variation of the amino acidT R Jones, M J Smithers, R F Betteridge, et al.Circulation|September 11, 2002
Coronary sinus-ventricular accessory connections producing posteroseptal and left posterior accessory pathways: incidence and electrophysiological identificationYingxian Sun, Mauricio Arruda, Kenichiro Otomo, et al.Cancer|August 8, 2013
Volumetric tumor growth in advanced non-small cell lung cancer patients with EGFR mutations during EGFR-tyrosine kinase inhibitor therapy: developing criteria to continue therapy beyond RECIST progressionMizuki Nishino, Suzanne E Dahlberg, Stephanie Cardarella, et al.Journal of Medicinal Chemistry|November 1, 1990
Quinazoline antifolate thymidylate synthase inhibitors: 2'-fluoro-N10-propargyl-5,8-dideazafolic acid and derivatives with modifications in the C2 positionA L Jackman, P R Marsham, T J Thornton, et al.The Journal of Investigative Dermatology|May 1, 1995
Increased expression of vascular permeability factor (vascular endothelial growth factor) in bullous pemphigoid, dermatitis herpetiformis, and erythema multiformeL F Brown, T J Harrist, K T Yeo, et al.Pageof 189